Latest / Stock Movers / Novo Nordisk Up, Vestas Surges, Babcock Rises
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market. Harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look at some of the stocks on
- 0:18Speaker 3: the move today in Europe. I'm Stephen Kraw with Tom
- 0:20Speaker 3: McKenzie and we're joined by Bloomberg'schoemla for more. Chloe, good morning.
- 0:24Speaker 3: Let's start with Novo Nordisk advancing as much as five percent.
- 0:28Speaker 4: What's going on, Yeah, so quite a bit of a
- 0:30Speaker 4: boost this morning after a tough year for Nova Nordis.
- 0:33Speaker 4: So we'go vi, which is one of its blockbuster drugs,
- 0:36Speaker 4: got approved for a form of liver disease in the US,
- 0:39Speaker 4: and that means that Nova has access to that market
- 0:42Speaker 4: before its biggest rival, Eli Lilly, and we are talking
- 0:46Speaker 4: about quite a massive market. So this particular form of
- 0:49Speaker 4: viva disease is known as MASH and it is conditioned
- 0:53Speaker 4: that affects six percent of US adults, so that means
- 0:56Speaker 4: fourteen zero point nine million people, so not a negligible market.
- 1:00Speaker 4: And this is obviously a relief for Nova after quite
- 1:03Speaker 4: a lot of setbacks over the last few months. Before today,
- 1:06Speaker 4: the stock was down about fifty percent year today. It
- 1:10Speaker 4: has lost quite a lot of its competitive edge to
- 1:13Speaker 4: Ela Lily in weight loss, and it's also had to
- 1:15Speaker 4: deal with a lot of copycats of its GLP one drugs,
- 1:18Speaker 4: so it has had a few setbacks. But this this
- 1:21Speaker 4: is quite good news for nov and Orders this morning,
- 1:23Speaker 4: and and access to that market is definitely going to
- 1:26Speaker 4: be a positive going forward.
- 1:28Speaker 1: And Chlovere you talked about relief for Nova and Orders
- 1:30Speaker 1: in the drug space, there's also really for Vestas when
- 1:33Speaker 1: it comes to the wind turbine space as well. That
- 1:36Speaker 1: stock is storing up fourteen but certainly the last time
- 1:38Speaker 1: I checked it was the biggest movers across European stock.
- 1:42Speaker 1: So what is the story when it comes to Vestas.
- 1:45Speaker 4: Yes, so for Vestas, but that's because of tax guidance,
- 1:48Speaker 4: So that doesn't sound that exciting, but it is quite interesting.
- 1:50Speaker 4: So we basically have new guidance on tax credits that
- 1:54Speaker 4: was issued by the IRS in the Treasury Department in
- 1:57Speaker 4: the US. They release that guide us on Friday, and
- 1:59Speaker 4: it's related to clean energy projects. And ALYS have looked
- 2:03Speaker 4: at that guidance and realized that those new rules were
- 2:06Speaker 4: more lenient, better than was originally feared and therefore kind
- 2:09Speaker 4: of much more manageable for vest tests than expected. And
- 2:13Speaker 4: this guidance is crucial because the wind and solar projects
- 2:16Speaker 4: in the US must start construction within the year or
- 2:19Speaker 4: be placed in service by the end of twenty twenty
- 2:21Speaker 4: seven to qualify for some of those tax credits. So
- 2:25Speaker 4: the clarity on that on those new rules is propping
- 2:28Speaker 4: up vest tests this morning.
- 2:30Speaker 3: I mean, personally I love a bit of upgrade dated
- 2:31Speaker 3: tax guidance. I think, yeah, right to be. That makes
- 2:34Speaker 3: my day. Usually, let's come back to the story here
- 2:37Speaker 3: in London and shares in Bobcocker higher. What's driving that?
- 2:41Speaker 4: Yeah, good day for Babcock as well. So it got
- 2:43Speaker 4: upgraded by RBC two and outperform rating. RBC mentioned that
- 2:48Speaker 4: the company had a really good relationship with the UK
- 2:50Speaker 4: Ministry of Defense, it had really good engineering no how,
- 2:53Speaker 4: and it also has a really strong management team and
- 2:56Speaker 4: all of that is kind of boosting prospects for six
- 3:00Speaker 4: So that's very positive for Babcock and it's already been
- 3:02Speaker 4: outperforming its peers and that kind of smaller UK defense
- 3:06Speaker 4: space to companies like Kinetic or Mailrose Industries for example,
- 3:09Speaker 4: Babcock is doing quite a lot better, so that's probably
- 3:12Speaker 4: going to be widening the gap a little bit further.
- 3:15Speaker 4: And Babcock is also benefiting from a broader rally in
- 3:18Speaker 4: the defense sector in Europe. So we also saw shares
- 3:21Speaker 4: it in Ryan Madawan, Bae, Handsalt, etc. Rise this morning,
- 3:24Speaker 4: and that's obviously ahead of the talks between Trump and Zelenski.
- 3:28Speaker 4: There's still quite a lot of uncertgety around what a
- 3:30Speaker 4: potential piece Deale might look like and what Trump has
- 3:33Speaker 4: promised putin on Friday, and all of that is kind
- 3:37Speaker 4: of boosting defense chares this morning.
- 3:40Speaker 2: The Stock Movers report from Bloomberg Radio. Check back with
- 3:44Speaker 2: us throughout the day for the latest roundup of companies
- 3:47Speaker 2: making news on Wall Street and for the latest market
- 3:50Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 3:55Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 3:58Speaker 2: the Bloomberg Business Up h